Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hip block could let patients move sooner after surgery

NCT ID NCT07239817

Symptom relief Sponsor: ASST Gaetano Pini-CTO Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new local anesthesia technique called PENG 360° to standard spinal anesthesia for people having hip replacement surgery after a fracture. The goal is to see if the new method controls pain just as well while allowing patients to move their leg sooner. One hundred adults will be randomly assigned to receive either the new block or spinal anesthesia, and researchers will track pain medicine use and leg movement for two days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ropivacaine and mepivacaine with epinephrine (local anesthetic mixture)
What this could lead to
If it works, this could offer a safer, motor-sparing pain control option for hip surgery patients, potentially reducing nausea and allowing faster recovery of leg movement.
What could go wrong
This is a small, early-phase trial with only 100 participants, so results may not apply to everyone. The new technique might not control pain as well as spinal anesthesia, and there is a risk of allergic reaction or infection at the injection site.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Provision of signed and dated informed consent form. * Scheduled for hip endoprosthesis surgery for femoral fracture with an anterior approach. * Age 18 years or older. * Willing and able to comply with the study protocol. Exclusion Criteria: * Failure to provide informed consent. * Age less than 18 years. * Known allergy to local anesthetics or other medications used in the protocol. * Presence of infection at the planned injection site. * Pre-existing hip prosthesis or prior major surgery on the same hip (e.g., revision surgery). * ASA physical status class \> IV. * Administration of intraoperative opiates or conversion to general anesthesia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia and analgesia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia Femoral Fractures femoral neck fracture hip fracture Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia and analgesia Arthroplasty, replacement, hip Hip fractures Local anesthesia infiltration Nerve block Pain, postoperative

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gaetano Pini-CTO

    RECRUITING

    Milan, 20122, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.